Please assess the completion status of the following clinical trial:

Trial Title: Open-Label Extension Study of GSK1605786A

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Previous participation in a GSK-sponsored study with GSK1605786A~* Written informed consent prior to any study-specific procedures~* Female subjects: To be eligible, females of child-bearing potential must be sexually inactive or commit to consistent and correct use of a contraceptive method of birth control with less than 1% failure rate~Exclusion Criteria:~* If female, is pregnant, has a positive pregnancy test or is breast-feeding, or is planning to become pregnant~* Subjects with known or suspected coeliac disease or a positive screening test for anti-tissue transglutaminase antibodies should have been excluded from enrolment into any induction study. Subjects in whom a diagnosis of coeliac disease is subsequently suspected should be tested for anti-tissue transglutaminase antibodies and excluded or withdrawn from the study upon positive test result~* Fixed symptomatic stenoses or strictures of small bowel or colon~* Enterocutaneous, abdominal or pelvic fistulae likely to require surgery during the study period~* Current sepsis or infections requiring intravenous antibiotic therapy greater than 2 weeks~* Evidence of hepatic dysfunction or viral hepatitis~* Subjects who have demonstrated safety or tolerability issues during participation in a previous study with GSK1605786A which, in the opinion of the investigator, was possibly related to study treatment and poses an unacceptable risk to the subject.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- GSK1605786A (Type: EXPERIMENTAL): 500 milligrams twice daily

Based on this trial design, predict the completion outcome and termination type (if applicable).